Passive immunotherapy of leukemia and other cancer.
D000818:Animals; D000906:Antibodies; D000917:Antibody Formation; D000918:Antibody Specificity; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001665:Binding Sites; D003165:Complement System Proteins; D000882:Haplorhini; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D007938:Leukemia / Q000188:drug therapy / Q000628:therapy*; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000628:therapy; D051379:Mice; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy*; D011414:Properdin; D051381:Rats; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000906:Antibodies; D000970:Antineoplastic Agents; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D011414:Properdin; D003165:Complement System Proteins